Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Alemtuzumab
Interferon Beta-1b may reverse axonal dysfunction in multiple sclerosis.
Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis.
Stopping Disease Modifying Therapy in Progressive Multiple Sclerosis - A Prospective Study
Placebo-controlled trial of oral laquinimod for multiple sclerosis.
Normal Appearing and Diffusely Abnormal White Matter in Patients with Multiple Sclerosis Assessed with Quantitative MR.
A genetic screen identifies genes essential for development of myelinated axons in zebrafish.
A full genome search in multiple sclerosis.
Interferon beta for secondary progressive multiple sclerosis.
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder.
Efficacy and safety study of RPC1063 in relapsing multiple sclerosis patients
JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab.
Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial.
Glatiramer acetate, an anti-demyelination drug, reduced rats' epileptic seizures induced by pentylenetetrazol via protection of myelin sheath.
Translating Fatigue to Human Performance.
Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis.
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.
Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
New insights into signaling during myelination in zebrafish.
Necrotizing skin lesion and radial nerve palsy in a patient treated with glatiramer acetate.
Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults.
Impact of MS during the critical window of brain development.
Drug Safety Labeling Changes
Revimmune (High-Dose Cyclophosphamide) for Autoimmune Diseases
The immunopathology of multiple sclerosis: an overview.

Pages